About 90% of CRC tumors express CEA, which has been reported to accelerate tumor progression, promote colon cancer cell adhesion to metastatic sites, and correlate with poor long-term survival outcomes [8, 9]. The gene discussed is CEACAM5; the disease is malignant colon neoplasm.